FCRL5 and autoimmune disease: Given that TLR7/9 activation has been implicated in the development and regulation of autoimmune diseases via anergy disruption (32, 33) and that hFcrl signaling increases TLR-mediated B cell activation (34, 35), we investigated the effect of Fcrl5 on TLR7/9 signaling.